Business Segments and Geographical Information

12 Months Ended

Jan. 01, 2022

Segment Reporting [Abstract]

Business Segments and Geographical Information

17. Business Segments and Geographical Information

We operate in one segment, ophthalmology. Substantially all of our long-term assets are located in the U.S. We develop, manufacture and market medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service and support activities.

Revenue information shown by product is as follows (in thousands):

	FY 2021		FY 2020
	Year Ended		Year Ended
	January 1, 2022		January 2, 2021
Cyclo G6	$	13,950	$	11,272
Retina		31,106		18,088
Other(1)		8,847		6,987
Total revenues	$	53,903	$	36,347
(1) Other includes service contract revenues of $1,386 and $1,263 recognized during fiscal years 2021 and 2020, respectively. Also includes $615 recognized revenue related to the exclusive distribution rights during fiscal year 2021. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region is as follows (in thousands):

	FY 2021		FY 2020
	Year Ended		Year Ended
	January 1, 2022		January 2, 2021
United States	$	25,561	$	19,312
Europe		13,573		8,006
Asia/Pacific Rim		12,226		7,062
Americas, excluding the U.S.		2,543		1,967
	$	53,903	$	36,347

Revenues are attributed to countries based on location of end customers. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during fiscal year 2021, representing 13.5%. The United States accounted for 47.4% of revenues in 2021. For fiscal year 2020 no individual country accounted for more than 10% of our sales, except for the United States, which accounted for 53.1%.